NEW STRATEGIES OF ANALYSIS WITH FLOW CYTOMETRY FOR THE DIAGNOSIS OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA

被引：0
|
作者：
Beneit, P. [1 ]
Tarin, F. [1 ]
Mora, E. [1 ]
Villarrubia, B. [1 ]
Mauricio, A. [1 ]
Fernandez, Ma [1 ]
Salazar, S. [1 ]
Jose De Paz, F. [1 ]
Verdu, J. [1 ]
Sanchez, S. [2 ]
Sanchez-Majano, J. [3 ]
Castano, V. [4 ]
Fernandez, C. [5 ]
Blanes, M. [4 ]
Verdu, J. Juan V. [1 ]
机构：
[1] Hosp Gen Univ Alicante, Hematol, Alicante, Spain
[2] Hosp Gen De Villajoyosa, Hematol, Alicante, Spain
[3] Hosp Gen Univ San Juan, Hematol, Alicante, Spain
[4] Hosp Gen Univ Elda, Hematol, Alicante, Spain
[5] Hosp Gen Vega Baja, Hematol, Alicante, Spain
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P749
引用
收藏
页码：314 / 314
页数：1
相关论文
共 50 条
  • [1] Minimal residual disease in multiple myeloma: Benefits of flow cytometry
    Galtseva, I. V.
    Davydova, Y. O.
    Kapranov, N. M.
    Julhakyan, H. L.
    Mendeleeva, L. P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : 12 - 20
  • [2] Minimal Residual Disease Detection by Flow Cytometry in Multiple Myeloma: Why and How?
    Roshal, Mikhail
    SEMINARS IN HEMATOLOGY, 2018, 55 (01) : 4 - 12
  • [3] Regulatory Perspective on Minimal Residual Disease Flow Cytometry Testing in Multiple Myeloma
    Gormley, Nicole J.
    Turley, Danielle M.
    Dickey, Jennifer S.
    Farrell, Ann T.
    Reaman, Gregory H.
    Stafford, Elizabeth
    Carrington, Lea
    Marti, Gerald E.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (01) : 73 - 80
  • [4] Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choice
    Owen, RG
    Rawstron, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (05) : 732 - 733
  • [5] MINIMAL RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA USING POLYCHROMATIC FLOW CYTOMETRY
    Rihova, Lucie
    Varmuzova, Tamara
    Zarbochova, Pavla
    Suska, Renata
    Penka, Miroslav
    Hajek, Roman
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (06) : 404 - 405
  • [6] Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity
    Flanders, Aaron
    Stetler-Stevenson, Maryalice
    Landgren, Ola
    BLOOD, 2013, 122 (06) : 1088 - 1089
  • [7] An analysis of the false negative rate of minimal residual disease measurement by multiparameter flow cytometry in multiple myeloma
    Austin, Michael
    O'Connor, Simon
    Morilla, Ricardo
    Pawlyn, Charlotte
    Kaiser, Martin F.
    Boyd, Kevin D.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (02) : E65 - E67
  • [8] Reliable monitoring of minimal residual disease in multiple myeloma:: how specific is flow cytometry?
    Lioznov, MV
    Cortes-Dericks, L
    Fehse, B
    Zander, AR
    Kröger, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S146 - S147
  • [9] Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma
    Foureau, David M.
    Paul, Barry A.
    Guo, Fei
    Lipford, Edward H.
    Fesenkova, Kateryna
    Tjaden, Elise
    Drummond, Kendra
    Bhutani, Manisha
    Atrash, Shebli
    Ndiaye, Ami
    Varga, Cindy
    Voorhees, Peter M.
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01): : E41 - E50
  • [10] Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma
    Foureau, David
    Bhutani, Manisha
    Guo, Fei
    Rigby, Katherine
    Leonidas, Marina
    Tjaden, Elise
    Fox, Andee
    Atrash, Shebli
    Paul, Barry
    Voorhees, Peter M.
    Usmani, Saad Z.
    CANCER MEDICINE, 2021, 10 (20): : 6933 - 6936
12345